Urinary L-FABP and anaemia: distinct roles of urinary markers in type 2 diabetes

Urinary liver-type fatty acid binding protein (L-FABP) and kidney injury molecule (KIM)-1, novel urinary biomarkers of renal tubulointerstitial function, have previously been associated with acute ischaemic kidney injury. We studied the clinical significance of urinary L-FABP, KIM-1 and N-acetyl-β-g...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Eynatten, Maximilian von (VerfasserIn) , Baumann, M. (VerfasserIn) , Heemann, U. (VerfasserIn) , Zdunek, D. (VerfasserIn) , Hess, G. (VerfasserIn) , Nawroth, Peter Paul (VerfasserIn) , Bierhaus, Angelika (VerfasserIn) , Humpert, Per Magnus (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 13 January 2010
In: European journal of clinical investigation
Year: 2010, Jahrgang: 40, Heft: 2, Pages: 95-102
ISSN:1365-2362
DOI:10.1111/j.1365-2362.2009.02220.x
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1111/j.1365-2362.2009.02220.x
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2362.2009.02220.x
Volltext
Verfasserangaben:M. Von Eynatten, M. Baumann, U. Heemann, D. Zdunek, G. Hess, P. P. Nawroth, A. Bierhaus, P. M. Humpert

MARC

LEADER 00000caa a2200000 c 4500
001 1859413676
003 DE-627
005 20240311124144.0
007 cr uuu---uuuuu
008 230913s2010 xx |||||o 00| ||eng c
024 7 |a 10.1111/j.1365-2362.2009.02220.x  |2 doi 
035 |a (DE-627)1859413676 
035 |a (DE-599)KXP1859413676 
035 |a (OCoLC)1425873912 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Eynatten, Maximilian von  |d 1974-  |e VerfasserIn  |0 (DE-588)129557250  |0 (DE-627)472716492  |0 (DE-576)29772116X  |4 aut 
245 1 0 |a Urinary L-FABP and anaemia  |b distinct roles of urinary markers in type 2 diabetes  |c M. Von Eynatten, M. Baumann, U. Heemann, D. Zdunek, G. Hess, P. P. Nawroth, A. Bierhaus, P. M. Humpert 
264 1 |c 13 January 2010 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 13.09.2023 
520 |a Urinary liver-type fatty acid binding protein (L-FABP) and kidney injury molecule (KIM)-1, novel urinary biomarkers of renal tubulointerstitial function, have previously been associated with acute ischaemic kidney injury. We studied the clinical significance of urinary L-FABP, KIM-1 and N-acetyl-β-glucosaminidase (NAG) as potential markers of renal function and chronic ischaemic injury in patients with diabetic nephropathy. 
650 4 |a Anaemia 
650 4 |a diabetic nephropathy 
650 4 |a microvascular complications 
650 4 |a tubulointerstitial marker 
650 4 |a type 2 diabetes 
700 1 |a Baumann, M.  |e VerfasserIn  |4 aut 
700 1 |a Heemann, U.  |e VerfasserIn  |4 aut 
700 1 |a Zdunek, D.  |e VerfasserIn  |4 aut 
700 1 |a Hess, G.  |e VerfasserIn  |4 aut 
700 1 |a Nawroth, Peter Paul  |d 1954-  |e VerfasserIn  |0 (DE-588)1020504897  |0 (DE-627)69123941X  |0 (DE-576)360517692  |4 aut 
700 1 |a Bierhaus, Angelika  |d 1962-2012  |e VerfasserIn  |0 (DE-588)1038392292  |0 (DE-627)757235271  |0 (DE-576)175591814  |4 aut 
700 1 |a Humpert, Per Magnus  |d 1974-  |e VerfasserIn  |0 (DE-588)122530748  |0 (DE-627)705941531  |0 (DE-576)293310181  |4 aut 
773 0 8 |i Enthalten in  |t European journal of clinical investigation  |d Oxford [u.a.] : Wiley-Blackwell, 1970  |g 40(2010), 2 vom: Feb., Seite 95-102  |h Online-Ressource  |w (DE-627)320441423  |w (DE-600)2004971-7  |w (DE-576)091142695  |x 1365-2362  |7 nnas  |a Urinary L-FABP and anaemia distinct roles of urinary markers in type 2 diabetes 
773 1 8 |g volume:40  |g year:2010  |g number:2  |g month:02  |g pages:95-102  |g extent:8  |a Urinary L-FABP and anaemia distinct roles of urinary markers in type 2 diabetes 
856 4 0 |u https://doi.org/10.1111/j.1365-2362.2009.02220.x  |x Resolving-System  |x Verlag  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2362.2009.02220.x  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230913 
993 |a Article 
994 |a 2010 
998 |g 122530748  |a Humpert, Per Magnus  |m 122530748:Humpert, Per Magnus  |d 910000  |d 910100  |e 910000PH122530748  |e 910100PH122530748  |k 0/910000/  |k 1/910000/910100/  |p 8  |y j 
998 |g 1038392292  |a Bierhaus, Angelika  |m 1038392292:Bierhaus, Angelika  |d 910000  |d 910100  |e 910000PB1038392292  |e 910100PB1038392292  |k 0/910000/  |k 1/910000/910100/  |p 7 
998 |g 1020504897  |a Nawroth, Peter Paul  |m 1020504897:Nawroth, Peter Paul  |d 910000  |d 910100  |e 910000PN1020504897  |e 910100PN1020504897  |k 0/910000/  |k 1/910000/910100/  |p 6 
999 |a KXP-PPN1859413676  |e 4375606029 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"Urinary L-FABP and anaemia","title":"Urinary L-FABP and anaemia","subtitle":"distinct roles of urinary markers in type 2 diabetes"}],"language":["eng"],"person":[{"family":"Eynatten","display":"Eynatten, Maximilian von","given":"Maximilian von","role":"aut","roleDisplay":"VerfasserIn"},{"given":"M.","roleDisplay":"VerfasserIn","role":"aut","display":"Baumann, M.","family":"Baumann"},{"family":"Heemann","given":"U.","roleDisplay":"VerfasserIn","role":"aut","display":"Heemann, U."},{"family":"Zdunek","display":"Zdunek, D.","roleDisplay":"VerfasserIn","role":"aut","given":"D."},{"family":"Hess","display":"Hess, G.","roleDisplay":"VerfasserIn","role":"aut","given":"G."},{"given":"Peter Paul","roleDisplay":"VerfasserIn","role":"aut","display":"Nawroth, Peter Paul","family":"Nawroth"},{"given":"Angelika","roleDisplay":"VerfasserIn","role":"aut","display":"Bierhaus, Angelika","family":"Bierhaus"},{"family":"Humpert","display":"Humpert, Per Magnus","given":"Per Magnus","roleDisplay":"VerfasserIn","role":"aut"}],"relHost":[{"title":[{"subtitle":"the journal of the European Society for Clinical Investigation","title":"European journal of clinical investigation","title_sort":"European journal of clinical investigation"}],"disp":"Urinary L-FABP and anaemia distinct roles of urinary markers in type 2 diabetesEuropean journal of clinical investigation","language":["eng"],"origin":[{"publisherPlace":"Oxford [u.a.] ; Oxford [u.a.] ; Oxford [u.a.]","dateIssuedKey":"1970","publisher":"Wiley-Blackwell ; Blackwell Science ; Blackwell","dateIssuedDisp":"1970-"}],"id":{"zdb":["2004971-7"],"eki":["320441423"],"issn":["1365-2362"],"doi":["10.1111/(ISSN)1365-2362"]},"physDesc":[{"extent":"Online-Ressource"}],"part":{"year":"2010","extent":"8","pages":"95-102","text":"40(2010), 2 vom: Feb., Seite 95-102","issue":"2","volume":"40"},"recId":"320441423","type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.1970/71 -"]}],"origin":[{"dateIssuedDisp":"13 January 2010","dateIssuedKey":"2010"}],"name":{"displayForm":["M. Von Eynatten, M. Baumann, U. Heemann, D. Zdunek, G. Hess, P. P. Nawroth, A. Bierhaus, P. M. Humpert"]},"id":{"eki":["1859413676"],"doi":["10.1111/j.1365-2362.2009.02220.x"]},"physDesc":[{"extent":"8 S."}],"recId":"1859413676","note":["Gesehen am 13.09.2023"],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a EYNATTENMAURINARYLFA1320